Search alternatives:
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1761
-
1762
-
1763
-
1764
-
1765
-
1766
Data_Sheet_1_Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nation...
Published 2022“…</p>Results<p>50,854 (56.0%) of them were male with a mean age of 74.9 (SD, 10.4) years. …”
-
1767
Results of peptide toxicity of each diet.
Published 2021“…<p>Values are given as mean ± SD for a total of 50 animals. Control group (I) - 0.295 nm, Curd mass (II)– 0.122 nm, Curd mass with flaxseed flour (III)– 0.113 nm, curd mass with celery root powder (IV) - 0.114 nm, Curd mass with bee bread (V)– 0.127 nm. …”
-
1768
The results of assay of blood serum biochemical parameters after experiment.
Published 2021“…*Values are given as mean ± SD for a total of 50 animals. p<0, 05 versus mice fed regular diet.…”
-
1769
-
1770
-
1771
Rhinorrhea-free days up to day 10.
Published 2024“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
-
1772
Vomit-free days up to day 10.
Published 2024“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
-
1773
Symptoms free-days up to day 10.
Published 2024“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
-
1774
Diarrhea-free days up to day 10.
Published 2024“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
-
1775
Nausea-free days up to day 10.
Published 2024“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
-
1776
Cough-free days up to day 10.
Published 2024“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
-
1777
Dyspnea-free days up to day 10.
Published 2024“…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
-
1778
Macrocyclic Receptor Exhibiting Unprecedented Selectivity for Light Lanthanides
Published 2009Subjects: -
1779
Macrocyclic Receptor Exhibiting Unprecedented Selectivity for Light Lanthanides
Published 2009Subjects: -
1780